These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25602010)

  • 1. Helicobacter pylori infection might prove the hygiene hypothesis in multiple sclerosis.
    Kira J
    J Neurol Neurosurg Psychiatry; 2015 Jun; 86(6):591-2. PubMed ID: 25602010
    [No Abstract]   [Full Text] [Related]  

  • 2. Association between Helicobacter pylori infection and multiple sclerosis: A systematic review and meta-analysis.
    Jaruvongvanich V; Sanguankeo A; Jaruvongvanich S; Upala S
    Mult Scler Relat Disord; 2016 May; 7():92-7. PubMed ID: 27237767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helicobacter pylori infection as a protective factor against multiple sclerosis risk in females.
    Pedrini MJ; Seewann A; Bennett KA; Wood AJ; James I; Burton J; Marshall BJ; Carroll WM; Kermode AG
    J Neurol Neurosurg Psychiatry; 2015 Jun; 86(6):603-7. PubMed ID: 25602009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helicobacter pylori may be a common denominator associated with systemic and multiple sclerosis.
    Kountouras J; Zavos C; Gavalas E; Deretzi G; Katsinelos P; Boura P; Polyzos SA; Venizelos I
    Joint Bone Spine; 2011 Mar; 78(2):222-3; author reply 223. PubMed ID: 21345710
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prevalence of Helicobacter pylori infection among patients with multiple sclerosis].
    Wender M
    Neurol Neurochir Pol; 2003; 37(1):45-8. PubMed ID: 12910828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extragastric manifestations of Helicobacter pylori infection: other Helicobacters.
    Moyaert H; Franceschi F; Roccarina D; Ducatelle R; Haesebrouck F; Gasbarrini A
    Helicobacter; 2008 Oct; 13 Suppl 1():47-57. PubMed ID: 18783522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis of association between Helicobacter pylori infection and multiple sclerosis.
    Yao G; Wang P; Luo XD; Yu TM; Harris RA; Zhang XM
    Neurosci Lett; 2016 May; 620():1-7. PubMed ID: 27033666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determining the IgM and IgG antibody titer against CMV and helicobacter pylori in the serum of multiple sclerosis patients comparing to the control group in Hamadan.
    Salim MA; Eftekharian MM; Taheri M; Yousef Alikhani M
    Hum Antibodies; 2017 Jul; 26(1):23-28. PubMed ID: 28505965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helicobacter pylori infection and skin disorders.
    Kutlubay Z; Zara T; Engin B; Serdaroğlu S; Tüzün Y; Yilmaz E; Eren B
    Hong Kong Med J; 2014 Aug; 20(4):317-24. PubMed ID: 25045884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicobacter pylori and multiple sclerosis.
    Gavalas E; Kountouras J; Deretzi G; Boziki M; Grigoriadis N; Zavos C; Venizelos I
    J Neuroimmunol; 2007 Aug; 188(1-2):187-9; author reply 190. PubMed ID: 17614142
    [No Abstract]   [Full Text] [Related]  

  • 11. A potential effect of active Helicobacter pylori infection on the risk of multiple sclerosis.
    Kountouras J; Boziki MK; Tzitiridou-Chatzopoulou M; Zavos C; Kazakos E
    Neurol Sci; 2024 Jul; 45(7):3543-3544. PubMed ID: 38409472
    [No Abstract]   [Full Text] [Related]  

  • 12. Relationship of Helicobacter pylori infection with gastrointestinal motility.
    Manes G; Malfertheiner P
    Ital J Gastroenterol Hepatol; 1999 Nov; 31(8):705-12. PubMed ID: 10730563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunological aspects of Helicobacter pylori infection].
    Bures J; Buresová E; Rejchrt S
    Acta Medica (Hradec Kralove) Suppl; 2002; 45(1):3-10. PubMed ID: 19569575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the hygiene hypothesis relevant for the risk of multiple sclerosis?
    Wendel-Haga M; Celius EG
    Acta Neurol Scand; 2017 Nov; 136 Suppl 201():26-30. PubMed ID: 29068485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helicobacter pylori nanoparticles as a potential treatment of conventional multiple sclerosis.
    Pezeshki MZ; Zarrintan S; Zarrintan MH
    Med Hypotheses; 2008; 70(6):1223. PubMed ID: 18242004
    [No Abstract]   [Full Text] [Related]  

  • 16. [Helicobacter pylori infection and eradication].
    Kato M; Hokari K; Nakagawa S; Ohira K; Kawarazaki M; Kagaya H; Takeda H; Sugiyama T; Asaka M
    Nihon Rinsho; 2000 Sep; 58(9):1804-7. PubMed ID: 11004806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal growth in young children with Helicobacter pylori infection.
    Ozçay F; Demir H; Ozen H; Gürakan F; Saltik IN; Yüce A; Koçak N
    J Pediatr Gastroenterol Nutr; 2002 Jul; 35(1):102. PubMed ID: 12142822
    [No Abstract]   [Full Text] [Related]  

  • 18. Laboratory-acquired Helicobacter pylori infection.
    Matysiak-Budnik T; Briet F; Heyman M; Mégraud F
    Lancet; 1995 Dec; 346(8988):1489-90. PubMed ID: 7491010
    [No Abstract]   [Full Text] [Related]  

  • 19. Helicobacter pylori infection and gastric motor dysfunction.
    Wingate DL
    J Physiol Pharmacol; 1996 Mar; 47(1):21-9. PubMed ID: 8777302
    [No Abstract]   [Full Text] [Related]  

  • 20. Helicobacter pylori infection is a potential protective factor against conventional multiple sclerosis in the Japanese population.
    Li W; Minohara M; Su JJ; Matsuoka T; Osoegawa M; Ishizu T; Kira J
    J Neuroimmunol; 2007 Mar; 184(1-2):227-31. PubMed ID: 17296235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.